| Literature DB >> 23651417 |
Anita D'Souza1, Stephen Ansell, Craig Reeder, Morie A Gertz.
Abstract
In this review, the key issues that pertain to Waldenström disease are discussed in a concise question-and-answer format. Diagnosis, prognosis, and indications for state-of-the-art therapy are updated. Current therapies presented at the 7th International Workshop for Waldenström Macroglobulinaemia are included.Entities:
Keywords: IgM monoclonal proteins; Waldenström macroglobulinaemia; hyperviscosity; lymphoplasmacytic lymphoma; stem cell transplant
Mesh：
Substances：
Year: 2013 PMID： 23651417 DOI： 10.1111/bjh.12367
Source DB: PubMed Journal: Br J Haematol ISSN： 0007-1048 Impact factor: 6.998